B H S, Bidkar V, Prathipati K, Dabhekar S, Selvaraj K, G D
Cureus. 2024; 16(4):e59007.
PMID: 38800245
PMC: 11127724.
DOI: 10.7759/cureus.59007.
Yang C, Yang Y, Zhao G, Wang H, Dai Y, Huang X
Biosensors (Basel). 2023; 13(7).
PMID: 37504151
PMC: 10377552.
DOI: 10.3390/bios13070753.
Kushner I
Front Immunol. 2023; 14:1150103.
PMID: 36936978
PMC: 10018134.
DOI: 10.3389/fimmu.2023.1150103.
Semitala F, Chaisson L, Dowdy D, Armstrong D, Opira B, Aman K
Trials. 2022; 23(1):399.
PMID: 35550621
PMC: 9096738.
DOI: 10.1186/s13063-022-06371-0.
Dhana A, Hamada Y, Kengne A, Kerkhoff A, Rangaka M, Kredo T
Lancet Infect Dis. 2021; 22(4):507-518.
PMID: 34800394
PMC: 8942858.
DOI: 10.1016/S1473-3099(21)00387-X.
Therapeutic Lowering of C-Reactive Protein.
Jimenez R, Szalai A
Front Immunol. 2021; 11:619564.
PMID: 33633738
PMC: 7901964.
DOI: 10.3389/fimmu.2020.619564.
C-Reactive Protein Promotes the Expansion of Myeloid Derived Cells With Suppressor Functions.
Jimenez R, Kuznetsova V, Connelly A, Hel Z, Szalai A
Front Immunol. 2019; 10:2183.
PMID: 31620123
PMC: 6759522.
DOI: 10.3389/fimmu.2019.02183.
Serum IgM and C-Reactive Protein Binding to Phosphorylcholine of Nontypeable Increases Complement-Mediated Killing.
Langereis J, van der Pasch E, de Jonge M
Infect Immun. 2019; 87(8).
PMID: 31109949
PMC: 6652778.
DOI: 10.1128/IAI.00299-19.
Point-of-care C-reactive protein and risk of early mortality among adults initiating antiretroviral therapy.
Chaisson L, Semitala F, Asege L, Mwebe S, Katende J, Nakaye M
AIDS. 2019; 33(5):895-902.
PMID: 30649057
PMC: 6423982.
DOI: 10.1097/QAD.0000000000002130.
Association of Elevated C-Reactive Protein with Severe Periodontitis in Hypertensive Patients in Lagos, Nigeria: A Pilot Study.
Alade G, Ayanbadejo P, Umeizudike K, Ajuluchukwu J
Contemp Clin Dent. 2018; 9(Suppl 1):S95-S99.
PMID: 29962772
PMC: 6006880.
DOI: 10.4103/ccd.ccd_104_18.
C-Reactive Protein Impairs Dendritic Cell Development, Maturation, and Function: Implications for Peripheral Tolerance.
Jimenez R, Wright T, Jones N, Wu J, Gibson A, Szalai A
Front Immunol. 2018; 9:372.
PMID: 29556231
PMC: 5845098.
DOI: 10.3389/fimmu.2018.00372.
Point-of-care C-reactive protein-based tuberculosis screening for people living with HIV: a diagnostic accuracy study.
Yoon C, Semitala F, Atuhumuza E, Katende J, Mwebe S, Asege L
Lancet Infect Dis. 2017; 17(12):1285-1292.
PMID: 28847636
PMC: 5705273.
DOI: 10.1016/S1473-3099(17)30488-7.
Diagnostic accuracy of C-reactive protein for active pulmonary tuberculosis: a meta-analysis.
Yoon C, Chaisson L, Patel S, Allen I, Drain P, Wilson D
Int J Tuberc Lung Dis. 2017; 21(9):1013-1019.
PMID: 28826451
PMC: 5633000.
DOI: 10.5588/ijtld.17.0078.
Energetics and the immune system: Trade-offs associated with non-acute levels of CRP in adolescent Gambian girls.
Shattuck-Heidorn H, Reiches M, Prentice A, Moore S, Ellison P
Evol Med Public Health. 2016; 2017(1):27-38.
PMID: 28003312
PMC: 5381351.
DOI: 10.1093/emph/eow034.
To study the levels of C - reactive protein and total leucocyte count in patients operated of open and laparoscopic cholecystectomy.
Kohli R, Bansal E, Gupta A, Matreja P, Kaur K
J Clin Diagn Res. 2014; 8(6):NC06-8.
PMID: 25121022
PMC: 4129338.
DOI: 10.7860/JCDR/2014/7094.4487.
Point-of-care C-reactive protein testing to facilitate implementation of isoniazid preventive therapy for people living with HIV.
Yoon C, Davis J, Huang L, Muzoora C, Byakwaga H, Scibetta C
J Acquir Immune Defic Syndr. 2013; 65(5):551-6.
PMID: 24346636
PMC: 3999220.
DOI: 10.1097/QAI.0000000000000085.
Incidence and management of infections in patients with acute leukemia following chemotherapy in general wards.
Biswal S, Godnaik C
Ecancermedicalscience. 2013; 7:310.
PMID: 23634180
PMC: 3634721.
DOI: 10.3332/ecancer.2013.310.
Comparison of microalbuminuria with hs-CRP and low density lipoprotein levels in nondiabetic, nonhypertensive myocardial infarction patients.
Goud B, Nayal B, Devi O, Devaki R, Avinash S, Satisha T
J Cardiovasc Dis Res. 2012; 3(4):287-9.
PMID: 23233772
PMC: 3516008.
DOI: 10.4103/0975-3583.102702.
Pneumococcal surface protein A inhibits complement deposition on the pneumococcal surface by competing with the binding of C-reactive protein to cell-surface phosphocholine.
Mukerji R, Mirza S, Roche A, Widener R, Croney C, Rhee D
J Immunol. 2012; 189(11):5327-35.
PMID: 23105137
PMC: 3517878.
DOI: 10.4049/jimmunol.1201967.
Plasma lipid profiling across species for the identification of optimal animal models of human dyslipidemia.
Yin W, Carballo-Jane E, McLaren D, Mendoza V, Gagen K, Geoghagen N
J Lipid Res. 2011; 53(1):51-65.
PMID: 22021650
PMC: 3243481.
DOI: 10.1194/jlr.M019927.